Keywords = HePG2
Decitabine attenuates the anti-cancer effect of doxorubicin by repressing ECDH1 and inducing SNAI1 and BCL2 in HepG2 hepatocellular carcinoma cells.

Volume 66, Issue 13, December 2023, Pages 745-754

10.21608/ejchem.2023.181289.7341

Mohamed Abohendia; Ayman Mohamed Metwally; walaa hozayen; Ahmed O. El-Gendy; Abdel Hady A. Abdel Wahab


GFBR3 Promoter Methylation Is A Prognostic Indicator And Not Responding To Decitabine Treatment In Hepatocellular Carcinoma

Volume 66, Issue 13, December 2023, Pages 807-817

10.21608/ejchem.2023.188752.7492

mohamed ibrahim abou hendia; Ayman Mohamed Metwally; walaa hozayen; Ahmed Osama El-Gendy; Sabrin Abdel-Wahab; Abdel Hady A Abdel Wahab


Synthesis, Cytotoxicity and Molecular Docking of Some Schiff Bases Derived Quinazolinone Bearing Pyrazoline

Volume 62, Special Issue (Part 1) Innovation in Chemistry, December 2019, Pages 197-209

10.21608/ejchem.2019.10116.1666

Sahar El-Sakka; Mohamed Soliman; Eman El-Sholkany